Association between Adherence to Guideline-Recommended Preventive Medications and In-Hospital Mortality among Non-Reperfused ST-Elevation Myocardial Infarction Patients Admitted to a Tertiary Care Academic Center in a Developing Country
Authors
Sylvi Irawati
University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, Groningen, NL; Center for Medicines Information and Pharmaceutical Care, Faculty of Pharmacy, Universitas Surabaya, Surabaya, ID; Department of Clinical and Community Pharmacy, Faculty of Pharmacy, Universitas Surabaya, Surabaya
Surya Dharma
Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular
Research Center, National Cardiovascular Center Harapan Kita, Jakarta
Katja Taxis
University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, Groningen
Thang Nguyen
Department of Pharmacology and Clinical Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho
Nunung Nursyarofah
Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta
Bob Wilffert
University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, Groningen; University of Groningen, Department of Clinical Pharmacy & Pharmacology, University Medical Center Groningen, Groningen
Eelko Hak
University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, -Epidemiology and -Economics, Groningen
DOI: https://doi.org/10.5334/gh.394 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jun 27, 2019
Accepted on: Oct 23, 2019
Published on: Feb 6, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2020 Sylvi Irawati, Surya Dharma, Katja Taxis, Thang Nguyen, Nunung Nursyarofah, Bob Wilffert, Eelko Hak, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.